User profiles for "author:Elena Bargagli"

elena bargagli

Università di Siena
Verified email at unisi.it
Cited by 9151

[HTML][HTML] Oxidative stress in the pathogenesis of diffuse lung diseases: a review

E Bargagli, C Olivieri, D Bennett, A Prasse… - Respiratory …, 2009 - Elsevier
Oxidative stress is an imbalance between oxidants (reactive oxygen and nitrogen species)
and antioxidants that may affect lipids, DNA, carbohydrates and proteins. The lung is …

Sarcoidosis: a review for the internist

E Bargagli, A Prasse - Internal and Emergency Medicine, 2018 - Springer
Sarcoidosis is a systemic granulomatous lung disease of unknown origin affecting people of
any age, mainly young adults. The disease is extremely heterogeneous with an …

Diagnosis of hypersensitivity pneumonitis in adults: an official ATS/JRS/ALAT clinical practice guideline

G Raghu, M Remy-Jardin, CJ Ryerson… - American journal of …, 2020 - atsjournals.org
Background: This guideline addresses the diagnosis of hypersensitivity pneumonitis (HP). It
represents a collaborative effort among the American Thoracic Society, Japanese …

Oxidant/antioxidant disequilibrium in idiopathic pulmonary fibrosis pathogenesis

P Cameli, A Carleo, L Bergantini, C Landi, A Prasse… - Inflammation, 2020 - Springer
Idiopathic pulmonary fibrosis is characterised by abnormal reepithelialisation and
remodelling consequent to persistent stimuli or injury. The involvement of oxidative stress in …

Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis

A Prasse, C Probst, E Bargagli, G Zissel… - American journal of …, 2009 - atsjournals.org
Rationale: Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease with a poor
prognosis. There is great effort to find predictors of outcome. Conclusive data for any serum …

Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study

A Bettiol, ML Urban, L Dagna, V Cottin… - Arthritis & …, 2022 - Wiley Online Library
Objective Mepolizumab proved to be an efficacious treatment for eosinophilic
granulomatosis with polyangiitis (EGPA) at a dose of 300 mg every 4 weeks in the …

Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study

M Mura, MA Porretta, E Bargagli… - European …, 2012 - Eur Respiratory Soc
The natural history of idiopathic pulmonary fibrosis (IPF) is not well defined and its clinical
course is variable. We sought to investigate the survival and incidence of acute …

Phenotypes of organ involvement in sarcoidosis

JC Schupp, S Freitag-Wolf, E Bargagli… - European …, 2018 - Eur Respiratory Soc
Sarcoidosis is a highly variable, systemic granulomatous disease of hitherto unknown
aetiology. The GenPhenReSa (Genotype–Phenotype Relationship in Sarcoidosis) project …

Serum KL‐6 concentrations as a novel biomarker of severe COVID‐19

M d'Alessandro, P Cameli, RM Refini… - Journal of medical …, 2020 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2–induced direct cytopathic effects against
type I and II pneumocytes mediate lung damage. Krebs von den Lungen‐6 (KL‐6) is mainly …

BAL cell gene expression is indicative of outcome and airway basal cell involvement in idiopathic pulmonary fibrosis

A Prasse, H Binder, JC Schupp, G Kayser… - American journal of …, 2019 - atsjournals.org
Rationale: Idiopathic pulmonary fibrosis (IPF) is a fatal disease with a variable and
unpredictable course. Objectives: To determine whether BAL cell gene expression is …